{"id":"https://genegraph.clinicalgenome.org/r/60aa1d7d-2b8a-4cca-84be-a537e7d8b536v2.0","type":"EvidenceStrengthAssertion","dc:description":"There is a definitive association between alteration of the NRAS gene and Noonan syndrome (NS). The maximum amount of scorable genetic evidence has been published showing de novo as well as non-de novo variants occur in NRAS in patients with NS (Altmuller et al., 2017; Cirstea et al., 2010; Denayer et al., 2012; Runtuwene et al., 2011). The NRAS gene is also located in the Ras/MAPK pathway, which is associated with the NS phenotype and variants found in NS patients in this gene disrupt the RAS pathway function as demonstrated by zebrafish models (Aoki et al., 2016; Rauen, 2013; Runtuwene et al., 2011). Of note, NRAS has also been classified as Limited in association with Costello syndrome, cardiofaciocutaneous syndrome, and NS with multiple lentigines. The ClinGen RASopathy Expert Panel found no evidence associating NRAS with NS-like disorder with loose anagen hair. This curation was approved by the ClinGen RASopathy Gene Curation Expert Panel on 5/30/18 (SOP Version 5).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/60aa1d7d-2b8a-4cca-84be-a537e7d8b536","GCISnapshot":"https://genegraph.clinicalgenome.org/r/34419b69-59c3-458b-a2a5-38a401679deb","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/34419b69-59c3-458b-a2a5-38a401679deb_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10021","date":"2021-03-09T20:22:27.506Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/34419b69-59c3-458b-a2a5-38a401679deb_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10021","date":"2018-05-30T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34419b69-59c3-458b-a2a5-38a401679deb_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34419b69-59c3-458b-a2a5-38a401679deb_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7fd80c73-b017-4ed8-99eb-f195327b3d5f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"scored due to de novo occurance prior, also segregated with disease in mother.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f835364-6b17-44d7-b50a-571e38b73cc9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19966803","rdfs:label":"Patient 3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":20,"phenotypeFreeText":"abnormal facial shape; macrocephaly; webbed neck; abnormality of the thorax; cryptorchidism; motor delay;  hyperkeratosis; curly hair; ichthyosis; acanthosis nigricans; scoliosis","previousTesting":true,"previousTestingDescription":"Negative for mutations in PTPN11, KRAS, SOS1, RAF1, BRAF, MEK1, MEK2.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7fd80c73-b017-4ed8-99eb-f195327b3d5f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19966803","allele":{"id":"https://genegraph.clinicalgenome.org/r/131dab5c-6ceb-4f79-8917-8f2e67336aca","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002524.5(NRAS):c.179G>A (p.Gly60Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/13903"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c9a521c1-5df5-4b6d-b36d-d5a85aa1c94f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant functionally characterized by Cirstea et al. 2010, and Runtuwene et al. 2011.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6fc378f-c2c8-4688-b036-52d10d2c67da","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22855653","rdfs:label":"Proband 3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"detectionMethod":"Variant functionally characterized by Cirstea et al. 2010, and Runtuwene et al. 2011.","phenotypeFreeText":"downslanting palpebral fissures; wide nasal bridge; depressed nasal bridge; thin upper lip vermilion; low-set, posteriorly rotated ears;  short neck; webbed neck; low posterior hairline; wide intermamillary distance; pectus excavatum;  retractile testis; coarctation of aorta; patent foramen ovale; abnormality of the aortic arch","phenotypes":["obo:HP_0012303","obo:HP_0012646","obo:HP_0001680","obo:HP_0006610","obo:HP_0000465","obo:HP_0000470","obo:HP_0000431","obo:HP_0001655","obo:HP_0000219","obo:HP_0000767","obo:HP_0000368","obo:HP_0002162","obo:HP_0000494","obo:HP_0005280"],"previousTesting":true,"previousTestingDescription":"Negative for variants in PTPN11, SOS1, RAF1, and KRAS.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c9a521c1-5df5-4b6d-b36d-d5a85aa1c94f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22855653","allele":{"id":"https://genegraph.clinicalgenome.org/r/64e25879-ca41-42ac-9f46-efd25ae62bcc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002524.5(NRAS):c.149C>T (p.Thr50Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/13902"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/34419b69-59c3-458b-a2a5-38a401679deb_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/753e1deb-88c7-4623-a488-bfd4943b3b21_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c719292d-782f-4d0b-bc20-ecfeb8032b4c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19966803","rdfs:label":"Patient 4","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"phenotypeFreeText":"polyhydramnios; pulmonic stenosis; abnormal facial shape; short stature; cryptorchidism; motor delay; curly hair","previousTesting":true,"previousTestingDescription":"Negative for mutations in PTPN11, KRAS, SOS1, RAF1, BRAF, MEK1, MEK2.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/753e1deb-88c7-4623-a488-bfd4943b3b21_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19966803","allele":{"id":"https://genegraph.clinicalgenome.org/r/64e25879-ca41-42ac-9f46-efd25ae62bcc"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e36e39c1-0743-4bd5-bd16-f76582d6b62f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This study screened 56 Dutch NS patients for variants in NRAS using PCR and terminator sequencing. These patients were previously found negative for variants in all other known NS-associated genes. They identified a NRAS variant in one individual. Variant was not foudn in 100 healthy controls.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bc9c1fa5-5213-41e6-8e68-754519142405","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21263000","rdfs:label":"Runtuwene 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":30,"phenotypeFreeText":"abnormal facial shape; low posterior hairline; webbed neck; pectus excavatum; cryptorchidism; mild global developmental delay; mild short stature","phenotypes":["obo:HP_0003502","obo:HP_0011342","obo:HP_0000767","obo:HP_0000028","obo:HP_0002162","obo:HP_0000465","obo:HP_0001999"],"previousTesting":true,"previousTestingDescription":"Negative for variants in known NS-associated genes.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e36e39c1-0743-4bd5-bd16-f76582d6b62f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21263000","allele":{"id":"https://genegraph.clinicalgenome.org/r/c06ab78c-8427-4d17-b294-76293978e98a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002524.5(NRAS):c.71T>A (p.Ile24Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/222971"}}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d72dd888-d40a-43ca-9225-c6d0c6263b3c_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e382fbe2-8b77-48a9-ba1a-726278f12d1e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19966803","rdfs:label":"Patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"detectionMethod":"This study screened  733 individuals with Noonan syndrome and no previously known mutations using HPLC and/or bidirectional Sanger sequencing. They identified 4 individuals with variants in the NRAS gene (3 de novo, 1 inherited).","phenotypeFreeText":"nuchal edema; hypertrophic cardiomyopathy; ventricular extrasystoles; abnormal facial shape; short stature; macrocephaly; webbed neck; abnormality of the thorax; cryptorchidism; myopia; motor delay; hyperkeratosis; curly hair; talipes equinovarus","previousTesting":true,"previousTestingDescription":"Negative for mutations in PTPN11, KRAS, SOS1, RAF1, BRAF, MEK1, MEK2.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d72dd888-d40a-43ca-9225-c6d0c6263b3c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19966803","allele":{"id":"https://genegraph.clinicalgenome.org/r/64e25879-ca41-42ac-9f46-efd25ae62bcc"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/82306f96-ad25-4dcd-aa42-4691b3510bfc_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This patient does not have ML but does have NS and can be scored unlike the Kraoua patients.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d76211b9-821e-4c89-98f9-0174caf3e298","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28594414","rdfs:label":"Patient 6","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/82306f96-ad25-4dcd-aa42-4691b3510bfc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28594414","allele":{"id":"https://genegraph.clinicalgenome.org/r/131dab5c-6ceb-4f79-8917-8f2e67336aca"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4dc7f030-a709-4aed-92b8-44ecc2fc4e2f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is a de novo occurance in an NS patient and it should be scored. Of note it is present in 2 alleles in gnomAD (european)","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc897d8b-e04d-41fa-84d4-102927c62a98","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28594414","rdfs:label":"Patient 13","ageType":"AgeAtReport","ageUnit":"Years","ageValue":1,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4dc7f030-a709-4aed-92b8-44ecc2fc4e2f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28594414","allele":{"id":"https://genegraph.clinicalgenome.org/r/d6a3ff25-dc78-4ba9-95be-4c0dde864b76","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002524.5(NRAS):c.35G>A (p.Gly12Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130425"}}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d45a9065-847a-4dc8-8997-0488fa97f379_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This study screened 115 NS patients without variants in other known NS-associated genes. They identified 3 individuals with variants in NRAS. A p.Pro34Leu variant did not segregate with disease in a family.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/705b742e-4c0d-4089-bab2-e09dc8af1684","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22855653","rdfs:label":"Proband 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"phenotypeFreeText":"motor delay; strabismus; hypertelorism; downslanted palpebral fissures; low-set ears; low posterior hairline; wide intermamillary distance; pectus excavatum; unilateral cryptorchidism; short stature; macrocephaly","phenotypes":["obo:HP_0004322","obo:HP_0001270","obo:HP_0002162","obo:HP_0000486","obo:HP_0000256","obo:HP_0000494","obo:HP_0000369","obo:HP_0000316","obo:HP_0012741","obo:HP_0000767","obo:HP_0006610"],"previousTesting":true,"previousTestingDescription":"Negative for variants in PTPN11, SOS1, RAF1, and KRAS.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d45a9065-847a-4dc8-8997-0488fa97f379_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22855653","allele":{"id":"https://genegraph.clinicalgenome.org/r/c06ab78c-8427-4d17-b294-76293978e98a"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3cc916f7-3bbe-4f76-928b-3e699f43f57c_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/288f3add-31e0-46c3-8119-733c4a50b330","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19966803","rdfs:label":"Patient 2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"detectionMethod":"This study screened  733 individuals with Noonan syndrome and no previously known mutations using HPLC and/or bidirectional Sanger sequencing. They identified 4 individuals with variants in the NRAS gene (3 de novo, 1 inherited).","phenotypeFreeText":"single umbilical artery; pulmonic stenosis; abnormality of the mitral valve; hypertrophic cardiomyopathy; abnormal facial shape; short stature; webbed neck; pectus excatvatum; motor delay; muscular hypotonia; delayed speech and language development; hyperkeratosis; sparse hair; ptosis","previousTesting":true,"previousTestingDescription":"Negative for mutations in PTPN11, KRAS, SOS1, RAF1, BRAF, MEK1, MEK2.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3cc916f7-3bbe-4f76-928b-3e699f43f57c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19966803","allele":{"id":"https://genegraph.clinicalgenome.org/r/131dab5c-6ceb-4f79-8917-8f2e67336aca"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":12}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/34419b69-59c3-458b-a2a5-38a401679deb_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34419b69-59c3-458b-a2a5-38a401679deb_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a56d601-5df2-4be8-ac6e-3402ecc964cb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/036f935d-6481-4d25-aec5-466962967440","type":"Finding","dc:description":"The NRAS gene is an established gene in the RAS/MAPK pathway which is associated with RASopathies including NS.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23875798","rdfs:label":"NRAS in RAS/MAPK pathway","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/34419b69-59c3-458b-a2a5-38a401679deb_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/997d3793-71e8-4068-bb47-89d35f23b266","type":"EvidenceLine","dc:description":"This study implicates the pathogenicty of the variants but does not provide support for NS exclusively and cannot be scored","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4796b48d-8072-4d6d-9a41-a6310e6bc916","type":"FunctionalAlteration","dc:description":"Both variants enhanced the phosphorylation of MEK and ERK in the presence of serum or epidermal growth factor. The G60E variant accumulated in the active, GTP-bound form but the T50I variant did not. The T50I crystal structure showed no structural rearrangements.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19966803","rdfs:label":"T50I and G60E variants"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7da851be-d0a0-40ff-8457-161619dfd98e","type":"EvidenceLine","dc:description":"Doesn't directly implicate NS","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6633eb24-52db-4319-b87a-740105f95f08","type":"FunctionalAlteration","dc:description":"The I24N, G12V, and G60E variants all enhanced MAPK activation compared to the control. T50I did not enhance the MAPK activation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21263000","rdfs:label":"Variants in 293T cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/34419b69-59c3-458b-a2a5-38a401679deb_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bc7ba94d-4f95-4cfe-9440-cc1d2128735f","type":"EvidenceLine","dc:description":"Doesn't directly implicate NS but does provide further support that this gene is associated with RASopathies","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8711d462-cf59-464a-a6cb-6ac09bf61fb1","type":"Finding","dc:description":"The study used MAPK inhibitors to attempt to rescue the phenotype of the I24N zebrafish embryos.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21263000","rdfs:label":"Rescue in I24N zebrafish","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8282645e-cfc6-43de-acf9-fe7561cbe597","type":"EvidenceLine","dc:description":"Implicate RASopathy phenotypes butdoes not provide evidence just for NS.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb07ab45-aeb1-48f1-a282-ebaedb2b158c","type":"Finding","dc:description":"Features similar to RASopathy","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21263000","rdfs:label":"Knock in zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Definitive","sequence":2267,"specifiedBy":"GeneValidityCriteria5","strengthScore":13.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Ism9pnPrS9c","type":"GeneValidityProposition","disease":"obo:MONDO_0018997","gene":"hgnc:7989","modeOfInheritance":"obo:HP_0000006"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_34419b69-59c3-458b-a2a5-38a401679deb-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}